XML 90 R80.htm IDEA: XBRL DOCUMENT
v3.23.3

SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | 9 Months Ended
--- | --- | --- | ---
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2023 | Sep. 30, 2023 | Sep. 30, 2022
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | $ 3,708 | $ 3,609 |  | $ 10,928 | $ 10,761
United States |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 1,766 | 1,758 |  | 5,183 | 5,170
International |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 1,942 | 1,851 |  | 5,745 | 5,591
BPS | Revision of Prior Period, Adjustment |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales |  | (8) | $ (2) |  | (26)
Other | Revision of Prior Period, Adjustment |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales |  | 8 | 2 |  | 26
Operating Segments | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 1,258 | 1,203 |  | 3,691 | 3,567
Operating Segments | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 744 | 735 |  | 2,218 | 2,205
Operating Segments | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 580 | 525 |  | 1,652 | 1,574
Operating Segments | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 1,109 | 1,100 |  | 3,294 | 3,286
Operating Segments | United States | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 709 | 708 |  | 2,087 | 2,100
Operating Segments | United States | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 551 | 548 |  | 1,607 | 1,609
Operating Segments | United States | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 195 | 173 |  | 550 | 494
Operating Segments | United States | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 299 | 293 |  | 883 | 869
Operating Segments | International | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 549 | 495 |  | 1,604 | 1,467
Operating Segments | International | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 193 | 187 |  | 611 | 596
Operating Segments | International | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 385 | 352 |  | 1,102 | 1,080
Operating Segments | International | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 810 | 807 |  | 2,411 | 2,417
Operating Segments | Infusion Therapies and Technologies | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 1,003 | 956 |  | 2,918 | 2,829
Operating Segments | Infusion Therapies and Technologies | United States | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 570 | 567 |  | 1,654 | 1,672
Operating Segments | Infusion Therapies and Technologies | International | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 433 | 389 |  | 1,264 | 1,157
Operating Segments | Advanced Surgery | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 255 | 247 |  | 773 | 738
Operating Segments | Advanced Surgery | United States | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 139 | 141 |  | 433 | 428
Operating Segments | Advanced Surgery | International | Medical Products and Therapies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 116 | 106 |  | 340 | 310
Operating Segments | Care and Connectivity Solutions | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 443 | 456 |  | 1,307 | 1,350
Operating Segments | Care and Connectivity Solutions | United States | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 317 | 339 |  | 926 | 991
Operating Segments | Care and Connectivity Solutions | International | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 126 | 117 |  | 381 | 359
Operating Segments | Front Line Care | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 301 | 279 |  | 911 | 855
Operating Segments | Front Line Care | United States | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 234 | 209 |  | 681 | 618
Operating Segments | Front Line Care | International | Healthcare Systems and Technologies |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 67 | 70 |  | 230 | 237
Operating Segments | Injectables and Anesthesia | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 351 | 325 |  | 987 | 961
Operating Segments | Injectables and Anesthesia | United States | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 195 | 173 |  | 550 | 494
Operating Segments | Injectables and Anesthesia | International | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 156 | 152 |  | 437 | 467
Operating Segments | Drug Compounding | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 229 | 200 |  | 665 | 613
Operating Segments | Drug Compounding | United States | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 0 | 0 |  | 0 | 0
Operating Segments | Drug Compounding | International | Pharmaceuticals |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 229 | 200 |  | 665 | 613
Operating Segments | Chronic Renal | Revision of Prior Period, Reclassification, Adjustment |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales |  | (8) | (16) |  | (23)
Operating Segments | Chronic Renal | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 921 | 934 |  | 2,730 | 2,744
Operating Segments | Chronic Renal | United States | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 233 | 236 |  | 689 | 675
Operating Segments | Chronic Renal | International | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 688 | 698 |  | 2,041 | 2,069
Operating Segments | Acute Therapies | Revision of Prior Period, Reclassification, Adjustment |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales |  | 8 | $ 16 |  | 23
Operating Segments | Acute Therapies | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 188 | 166 |  | 564 | 542
Operating Segments | Acute Therapies | United States | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 66 | 57 |  | 194 | 194
Operating Segments | Acute Therapies | International | Kidney Care |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 122 | 109 |  | 370 | 348
Other |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 17 | 46 |  | 73 | 129
Other | United States |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | 12 | 36 |  | 56 | 98
Other | International |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |
Net sales | $ 5 | $ 10 |  | $ 17 | $ 31

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_BPSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=srt_RestatementAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_MedicalProductsAndTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_HealthcareSystemsAndTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_KidneyCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_InfusionTherapiesAndTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_CareAndConnectivitySolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_FrontLineCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_InjectablesAndAnesthesiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PharmaceuticalCompoundingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_ChronicRenalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AcuteTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |